Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

计划入组 19 人 · 首次发布于 2005 年 9 月 5 日

Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

计划入组 19 人 · 首次发布于 2005 年 9 月 5 日

Tenosynovitis in Polyarticular and Oligoarticular Juvenile Idiopathic Arthritis

计划入组 106 人 · 首次发布于 2026 年 4 月 28 日

Naproxen(Aleve, Aleve PM, Aleve-D, Anaprox, Naprelan, Naprosyn, Sallus, Sudafed Sinus & Pain, Treximet, Vimovo)

C₁₄H₁₄O₃

PKM2 activator (oral, idiopathic pulmonary fibrosis/ rheumatoid arthritis)

Allogenic juvenile chondrocytes (Isto Biologics)

CARE Arthritis Ltd

Canada

Arthritis Innovation Corporation

Canada

The Stone Research Foundation For Sports Medicine and Arthritis

United States

FDA Expands Jylamvo Approval to Include Polyarticular Juvenile Idiopathic Arthritis and ALL

FDA Expands Methotrexate Approval for Pediatric ALL and Juvenile Idiopathic Arthritis

FDA Expands Methotrexate Approval for Pediatric ALL and pJIA with JYLAMVO Oral Solution